FIG. 3.
A polymorphic gene(s) in close linkage with the D11Mit48 microsatellite marker controls susceptibility to AI4 T-cell–induced diabetes through effects on a CD4 T-cell population other than CD25+ Tregs. A: Mice homozygous for the B6 allele (B6/B6) vs. heterozygous (NOD/B6) for D11Mit48 were, respectively, highly susceptible and resistant to AI4 T-cell–induced diabetes. Results represent three independent experiments. B: Insulitis scores are shown for nondiabetic heterozygous and homozygous BC1 NOD.Rag1null.AI4 splenocyte recipients. C and D: B6.H2g7 mice previously reconstituted with bone marrow from D11Mit48B6/B6 or D11Mit48NOD/B6 BC1 segregants are, respectively, susceptible or resistant to diabetes and insulitis induced by subsequently infused AI4 T-cells. E: Incidence of diabetes in 6- to 8-week-old female B6.H2g7.Rag1null, NOD.Rag1null, and F1.Rag1null recipients of 1 × 107 NOD.Rag1null.AI4 splenocytes. F: Incidence of diabetes in 6- to 8-week-old sublethally irradiated NOD and F1 recipients of 1 × 107 NOD.Rag1null.AI4 splenocytes. Recipients were also injected intraperitoneally with a CD25-depleting antibody (PC61 250 μg/mouse) 1 day before AI4 T-cell transfer. G and H: B6.H2g7.Rag1null mice infused with purified CD4+ T-cells from D11Mit48B6/B6 or D11Mit48NOD/B6 BC1 segregants are, respectively, susceptible or resistant to diabetes and insulitis induced by subsequently infused AI4 T-cells.